Crispr Therapeutics (CRSP) has disclosed a new risk, in the Innovation / R&D category. Crispr Therapeutics faces a significant business risk due ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Want to stay on top of the science and politics driving biotech ... showed that he had invested under $15,000 into CRISPR Therapeutics, which makes the sickle cell gene-editing therapy Casgevy.

Recent scientific advancements reveal a dramatic asteroid impact on the moon, creating canyons in moments, alongside ...

Approval for First CRISPR-Based Therapy: A Milestone for CRSP Stock The approval for Casgevy is a breakthrough for medical science, as it is the first approval for a CRISPR-based gene-editing ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

CRISPR, is a technology that can edit DNA at ... of the eye of a patient at the Casey Eye Institute at Oregon Health & Science University in Portland, US. It will take a few weeks to see if ...

Recent scientific discoveries include the identification of an ancient Antarctic bird as the oldest 'modern' bird, revelations about moon canyons formed by asteroid impact, Chile's struggle with light ...

SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers ... enable customers to develop next-generation mRNA and ...